Literature DB >> 23647804

Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors.

Shelli Kesler1, S M Hadi Hosseini, Charles Heckler, Michelle Janelsins, Oxana Palesh, Karen Mustian, Gary Morrow.   

Abstract

BACKGROUND: A majority of breast cancer (BC) survivors, particularly those treated with chemotherapy, experience long-term cognitive deficits that significantly reduce quality of life. Among the cognitive domains most commonly affected include executive functions (EF), such as working memory, cognitive flexibility, multitasking, planning, and attention. Previous studies in other populations have shown that cognitive training, a behavioral method for treating cognitive deficits, can result in significant improvements in a number of cognitive skills, including EF.
MATERIALS AND METHODS: In this study, we conducted a randomized controlled trial to investigate the feasibility and preliminary effectiveness of a novel, online EF training program in long-term BC survivors. A total of 41 BC survivors (21 active, 20 wait list) completed the 48 session training program over 12 weeks. The participants were, on average, 6 years after therapy.
RESULTS: Cognitive training led to significant improvements in cognitive flexibility, verbal fluency and processing speed, with marginally significant downstream improvements in verbal memory as assessed via standardized measures. Self-ratings of EF skills, including planning, organizing, and task monitoring, also were improved in the active group compared with the wait list group.
CONCLUSIONS: Our findings suggest that EF skills may be improved even in long-term survivors by using a computerized, home-based intervention program. These improvements may potentially include subjective EF skills, which suggest a transfer of the training program to real-world behaviors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Cognitive flexibility; Memory; Processing speed; Rehabilitation

Mesh:

Year:  2013        PMID: 23647804      PMCID: PMC3726272          DOI: 10.1016/j.clbc.2013.02.004

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  65 in total

Review 1.  Test review: Delis-Kaplan executive function system.

Authors:  Susan Homack; Donghyung Lee; Cynthia A Riccio
Journal:  J Clin Exp Neuropsychol       Date:  2005-07       Impact factor: 2.475

2.  Training of working memory impacts structural connectivity.

Authors:  Hikaru Takeuchi; Atsushi Sekiguchi; Yasuyuki Taki; Satoru Yokoyama; Yukihito Yomogida; Nozomi Komuro; Tohru Yamanouchi; Shozo Suzuki; Ryuta Kawashima
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

Review 3.  Cognitive function in breast cancer survivors.

Authors:  Janette Vardy
Journal:  Cancer Treat Res       Date:  2009

4.  Preliminary evidence for impaired rapid verb generation in schizophrenia.

Authors:  Steven Paul Woods; Michael Weinborn; Carolina Posada; Joy O'Grady
Journal:  Brain Lang       Date:  2006-12-11       Impact factor: 2.381

5.  A metacognitive contextual approach for facilitating return to work following acquired brain injury: three descriptive case studies.

Authors:  Tamara Ownsworth
Journal:  Work       Date:  2010

6.  Impact of working memory training on memory performance in old-old adults.

Authors:  Martin Buschkuehl; Susanne M Jaeggi; Sara Hutchison; Pasqualina Perrig-Chiello; Christoph Däpp; Matthias Müller; Fabio Breil; Hans Hoppeler; Walter J Perrig
Journal:  Psychol Aging       Date:  2008-12

7.  A cognitive training intervention increases resting cerebral blood flow in healthy older adults.

Authors:  Jennifer L Mozolic; Satoru Hayasaka; Paul J Laurienti
Journal:  Front Hum Neurosci       Date:  2010-03-12       Impact factor: 3.169

8.  A cognitive training intervention improves modality-specific attention in a randomized controlled trial of healthy older adults.

Authors:  Jennifer L Mozolic; Ashley B Long; Ashley R Morgan; Melissa Rawley-Payne; Paul J Laurienti
Journal:  Neurobiol Aging       Date:  2009-05-09       Impact factor: 4.673

9.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Yuelin Li; Charlotte T Furstenberg; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

10.  Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.

Authors:  Nelli Boykoff; Mona Moieni; Saskia Karen Subramanian
Journal:  J Cancer Surviv       Date:  2009-09-16       Impact factor: 4.442

View more
  78 in total

Review 1.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

2.  Effects of acupuncture versus cognitive behavioral therapy on cognitive function in cancer survivors with insomnia: A secondary analysis of a randomized clinical trial.

Authors:  Kevin T Liou; James C Root; Sheila N Garland; Jamie Green; Yuelin Li; Q Susan Li; Philip W Kantoff; Tim A Ahles; Jun J Mao
Journal:  Cancer       Date:  2020-04-22       Impact factor: 6.860

3.  Impact of transcranial direct current stimulation on sustained attention in breast cancer survivors: Evidence for feasibility, tolerability, and initial efficacy.

Authors:  Alexandra M Gaynor; Denise Pergolizzi; Yesne Alici; Elizabeth Ryan; Katrazyna McNeal; Tim A Ahles; James C Root
Journal:  Brain Stimul       Date:  2020-04-27       Impact factor: 8.955

Review 4.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

Review 5.  Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.

Authors:  M Lange; F Joly; J Vardy; T Ahles; M Dubois; L Tron; G Winocur; M B De Ruiter; H Castel
Journal:  Ann Oncol       Date:  2019-12-01       Impact factor: 32.976

Review 6.  Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.

Authors:  Jennifer N Vega; Julie Dumas; Paul A Newhouse
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-06       Impact factor: 4.105

Review 7.  Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

Authors:  Karen M Mustian; Calvin L Cole; Po Ju Lin; Matt Asare; Chunkit Fung; Michelle C Janelsins; Charles S Kamen; Luke J Peppone; Allison Magnuson
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

8.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

Review 9.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

Review 10.  Chemotherapy-related cognitive impairment in older patients with cancer.

Authors:  Kah Poh Loh; Michelle C Janelsins; Supriya G Mohile; Holly M Holmes; Tina Hsu; Sharon K Inouye; Meghan S Karuturi; Gretchen G Kimmick; Stuart M Lichtman; Allison Magnuson; Mary I Whitehead; Melisa L Wong; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.